Home 
Bratislava Medical Journal 2016 Bratislava Medical Journal Vol.116, No.3, p.125–132, 2016
Bratislava Medical Journal 2016 Bratislava Medical Journal Vol.116, No.3, p.125–132, 2016
Journal info
|
||||
Select Journal
Journals
Bratislava Medical Journal 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Bratislava Medical Journal Vol.116, No.3, p.125–132, 2016 |
||
| Title: Management of aortic graft infections – the present strategy and future perspectives | ||
| Author: V. Treska, B. Certik, J. Molacek | ||
| Abstract: Aortic graft infections (AGI) are serious complications of open and endovascular types of surgery with an incidence rate of 0.6–3 %. AGI are associated with 30–60 % perioperative mortality and 40–60 % morbidity rate with limb amputation rates between 10 % and 40 %. The economic cost of AGI is substantial. At the time of aortic reconstruction, almost 90 % of patients have one or more predisposing factors for AGI. The diagnosis is based on clinical symptomatology, laboratory markers, microbial cultures, and imaging modalities. The general principle of surgical treatment lies in the removal of infected graft, debridement of infected periprosthetic tissues, and vascular reconstruction by in situ or extra-anatomic bypass with long-term antibiotic therapy. The conservative treatment is used only for selected patients with endograft infection. This review summarizes the current knowledge about the incidence, predisposing factors, etiology, diagnosis, treatment options, and prevention of aortic vascular graft and endograft infections. With the growing number of endovascular procedures we can expect more cases of infected aortic endografts in patients with severe comorbidities in the near future, where the recent radical surgical approach (graft excision, debridement, and new revascularization) cannot be used. Therefore the less invasive, sophisticated and individualized treatment strategies will have to be used in search of the best therapeutic approach to each specific patient (Fig. 4, Ref. 82). |
||
| Keywords: aortic graft infections, incidence, etiology, management, treatment perspectives | ||
| Published online: 24-Feb-2016 | ||
| Year: 2016, Volume: 116, Issue: 3 | Page From: 125, Page To: 132 | |
| doi:10.4149/BLL_2016_024 |
||
|
|
 download file |
|